Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

2.040

+0.170 (9.09%)

At close: Nov 9, 2026, 4:00 PM EST

2.050

+0.010 (0.49%)

Pre-market: Nov 10, 2026, 4:59 AM EST

Foghorn Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	112.13	30.91	22.6	34.16	19.23	1.32
Revenue Growth	357.33%	36.75%	-33.83%	77.63%	1357.77%	206.74%
Cost of Revenue	77.66	85.47	94.53	109.69	105.62	80.33
Gross Profit	34.47	-54.56	-71.93	-75.53	-86.39	-79.01
Selling, General & Admin	25.53	27.55	28.36	32.37	30.75	21.73
Operating Expenses	25.53	27.55	28.36	32.37	30.75	21.73
Operating Income	8.94	-82.11	-100.29	-107.91	-117.14	-100.73
Interest Expense	-	-	-	-	-	-1.91
Interest & Investment Income	6.59	8.75	11.9	10.88	5.68	0.06
Other Non Operating Income (Expenses)	0.45	3.36	4.16	2.83	2.58	2.49
EBT Excluding Unusual Items	15.97	-70	-84.22	-94.2	-108.88	-100.09
Asset Writedown	-5.91	-5.91	-2.4	-	-	-
Other Unusual Items	1.63	1.63	-	-	-	-1.23
Pretax Income	9.42	-74.28	-86.62	-94.2	-108.88	-101.32
Income Tax Expense	-	-	-	4.23	-	-
Net Income	9.42	-74.28	-86.62	-98.43	-108.88	-101.32
Net Income to Common	9.42	-74.28	-86.62	-98.43	-108.88	-101.32
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	69	63	55	42	42	37
Shares Outstanding (Diluted)	69	63	55	42	42	37
Shares Change	10.35%	14.72%	30.79%	0.92%	11.89%	236.49%
EPS (Basic)	0.14	-1.18	-1.58	-2.34	-2.62	-2.73
EPS (Diluted)	0.13	-1.18	-1.58	-2.34	-2.62	-2.73
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-83.68	-86.15	-101.31	-119.33	192.4	-53.56
Free Cash Flow Per Share	-1.21	-1.37	-1.84	-2.84	4.63	-1.44
Gross Margin	30.74%	-176.51%	-	-221.15%	-	-
Operating Margin	7.97%	-265.64%	-443.70%	-315.93%	-609.20%	-7637.15%
Profit Margin	8.40%	-240.33%	-383.24%	-288.17%	-566.27%	-7681.58%
Free Cash Flow Margin	-74.63%	-278.72%	-448.24%	-349.38%	1000.63%	-4060.88%
EBITDA	10.42	-78.78	-97.17	-104.46	-113.82	-97.51
EBITDA Margin	9.29%	-254.86%	-	-	-	-
D&A For EBITDA	1.49	3.33	3.12	3.45	3.32	3.23
EBIT	8.94	-82.11	-100.29	-107.91	-117.14	-100.73
EBIT Margin	7.97%	-265.64%	-	-	-	-

SEC Filings: 10-K · 10-Q